Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Asset Writedowns and Impairment (2022 - 2024)

Intelligent Bio Solutions has reported Asset Writedowns and Impairment over the past 3 years, most recently at $263.0 for Q1 2024.

  • For Q1 2024, Asset Writedowns and Impairment fell 99.84% year-over-year to $263.0; the TTM value through Mar 2024 reached $72115.0, changed N/A, while the annual FY2023 figure was $189670.0, N/A changed from the prior year.
  • Asset Writedowns and Impairment for Q1 2024 was $263.0 at Intelligent Bio Solutions, down from $1165.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $163916.0 in Q1 2023 and troughed at $263.0 in Q1 2024.
  • A 3-year average of $43158.2 and a median of $12877.0 in 2022 define the central range for Asset Writedowns and Impairment.
  • Biggest five-year swings in Asset Writedowns and Impairment: tumbled 94.92% in 2023 and later tumbled 99.84% in 2024.
  • Year by year, Asset Writedowns and Impairment stood at $22918.0 in 2022, then tumbled by 94.92% to $1165.0 in 2023, then tumbled by 77.42% to $263.0 in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for INBS at $263.0 in Q1 2024, $1165.0 in Q4 2023, and $67851.0 in Q3 2023.